Alzheimer's disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease)

被引:14
|
作者
Kang, Tae Hyuk [1 ]
Friedmann, Theodore [2 ]
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA
[2] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
Neurogenesis; Neurodevelopment disease; Neurodegenerative disease; Alzheimer's disease; HPRT; Lesch-Nyhan disease; NEURONAL DIFFERENTIATION; RECEPTORS; GROWTH; NUCLEOTIDE; PATHWAYS; ACTIVATION; COMPLEX; PROTEIN; MODEL;
D O I
10.1016/j.neulet.2015.01.042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transcriptomic studies of murine D3 embryonic stem (ES) cells deficient in the purinergic biosynthetic function hypoxanthine guanine phosphoribosyltransferase (HPRT) and undergoing dopaminergic neuronal differentiation has demonstrated a marked shift from neuronal to glial gene expression and aberrant expression of multiple genes also known to be aberrantly expressed in Alzheimer's and other CNS disorders. Such genetic dysregulations may indicate some shared pathogenic metabolic mechanisms in diverse CNS diseases. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [21] Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease
    Hyland, K
    Kasim, S
    Egami, K
    Arnold, LA
    Jinnah, HA
    JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (02) : 165 - 178
  • [22] Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease
    Visser, JE
    Smith, DW
    Moy, SS
    Breese, GR
    Friedmann, T
    Rothstein, JD
    Jinnah, HA
    DEVELOPMENTAL BRAIN RESEARCH, 2002, 133 (02): : 127 - 139
  • [23] HPRT-Deficiency Dysregulates cAMP-PKA Signaling and Phosphodiesterase 10A Expression: Mechanistic Insight and Potential Target for Lesch-Nyhan Disease?
    Guibinga, Ghiabe-Henri
    Murray, Fiona
    Barron, Nikki
    PLOS ONE, 2013, 8 (05):
  • [24] Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency
    Schretlen, DJ
    Harris, JC
    Park, KS
    Jinnah, HA
    Del Pozo, NO
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2001, 7 (07) : 805 - 812
  • [25] Genotype-Phenotype Correlations in Lesch-Nyhan Disease MOVING BEYOND THE GENE
    Fu, Rong
    Jinnah, H. A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (05) : 2997 - 3008
  • [26] ELEVATED AMP PYROPHOSPHORYLASE ACTIVITY IN CONGENITAL IMP PYROPHOSPHORYLASE DEFICIENCY (LESCH-NYHAN DISEASE)
    RUBIN, CS
    BALIS, ME
    PIOMELLI, S
    BERMAN, PH
    DANCIS, J
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1969, 74 (05): : 732 - +
  • [27] Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells
    Urbach, A
    Schuldiner, M
    Benvenisty, N
    STEM CELLS, 2004, 22 (04) : 635 - 641
  • [28] Gene expression and mRNA editing of serotonin receptor 2C in brains of HPRT gene knock-out mice, an animal model of Lesch-Nyhan disease
    Bertelli, Matteo
    Alushi, Brunilda
    Veicsteinas, Arsenio
    Jinnah, H. A.
    Micheli, Vanna
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (08) : 1061 - 1063
  • [29] Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines
    Pinto, CS
    Jinnah, HA
    Shirley, TL
    Nyhan, WL
    Seifert, R
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (06) : 1579 - 1586
  • [30] A DOPAMINE DEFICIENCY MODEL OF LESCH-NYHAN DISEASE - THE NEONATAL-6-OHDA-LESIONED RAT
    BREESE, GR
    CRISWELL, HE
    DUNCAN, GE
    MUELLER, RA
    BRAIN RESEARCH BULLETIN, 1990, 25 (03) : 477 - 484